Corbus Pharmaceuticals (CRBP) has released an update to notify the public and investors about its officers.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Rachael Brake, Ph.D., the Chief Scientific Officer of Corbus Pharmaceuticals Holdings, Inc., has resigned, with her departure set for February 19, 2024. This change in leadership could impact the company’s direction and investor’s perspectives.
For further insights into CRBP corporate activity, check out TipRanks’ Insiders Trading Activity page.
For a comprehensive understanding of the announcement, you can read the full document here.
